Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heart sounds are the discrete auditory vibrations produced by the mechanical activities of the heart, primarily resulting from the closure of heart valves and the associated turbulence of blood flow during the cardiac cycle [1][2]. The two primary sounds, S1 (lub) and S2 (dub), correspond to the closure of the atrioventricular and semilunar valves, respectively, marking the beginning of systole and diastole [1]. Abnormal sounds, such as S3 and S4 gallops or various murmurs, often indicate underlying pathologies like heart failure, valvular dysfunction, or structural defects [2][3]. While heart sounds are not molecular targets (such as receptors or enzymes) that drugs can bind to, they are critical clinical indicators used to monitor cardiac health and the hemodynamic response to therapy [3]. Pharmacological agents like diuretics, beta-blockers, or inotropes may alter these sounds by improving cardiac function or reducing fluid overload, but the sound itself remains a physiological sign rather than a therapeutic target [1][3].
Not applicable; heart sounds are acoustic results of mechanical activity rather than molecular targets for drug binding.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heart sounds (HS).